Back to Agenda
Session 4, Track B: Pharmacovigilance Inspections in Latin America – Current Scenario, Expectations and Trends
Session Chair(s)
Arthur Bueno, PHARMD, MBA
Pharmacovigilance Affiliate Lead - Brazil, Eli Lilly and Company, Brazil
In this session, speakers will discuss the current scenario for Pharmacovigilance Inspections in Latin America, considering the main concerns, trends and the expectations from the Regulatory Bodies for the Pharmacovigilance systems for the regulated sector.
Learning Objective : - Recognize the main trends and concerns for Pharmacovigilance Inspections in Latin America
- Understand the Regulatory expectations for the Pharmacovigilance Processes set-up for the regulated sector in Latin America
- Identify opportunities for Pharmacovigilance processes alignments/improvements considering the lessons learned from Pharmacovigilance Inspections in Latin America
Speaker(s)
Raphael Elmadjian Pareschi, PHARMD, MBA
Patient Safety Lead/ Head of Pharmacovigilance Brazil, Roche, Brazil
Session 4, Track B: Pharmacovigilance Inspections in Latin America – Current Scenario, Expectations and Trends
Flavia Neves Rocha Alves, MPH
PV Department Leader, ANVISA, Brazil
Pharmacovigilance Inspections in Latin America: Current Scenario, Expectations and Trends – Scenario for Brazil
Xiomara Vega Cruz, MHS
Head of the National Pharmacovigilance Center, Ministry of Health of Costa Rica, Costa Rica
Pharmacovigilance Inspections in Latin America – Current Scenario, Expectations and Trends
Kelly Elizabeth Serrano Mestanza
Head of Pharmacovigilance Team, DIGEMID, Peru
Pharmacovigilance Inspections in Peru: Current scenario, Expectations and Trends
Have an account?